Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)Makoto Yamasaki, Yuichiro� Doki, Takushi Yasuda et al.|Annals of Oncology|2016Cited by 128
Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the EsophagusMakoto Yamasaki, Yuichiro� Doki, Hiroshi Miyata et al.|Oncology|2011Cited by 102
Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancerHiroshi Miyata, Yuichiro� Doki, Masaaki Motoori et al.|Clinical Nutrition|2011Cited by 97
Randomized study of the clinical effects of ω-3 fatty acid–containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancerHiroshi Miyata, Yuichiro� Doki, Masahiko Yano et al.|Nutrition|2016Cited by 54
Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal CancerOsamu Shiraishi, Takushi Yasuda, Makoto Yamasaki et al.|Oncology|2016Cited by 44